Nymox Pharmaceutical Corporation (Nymox) is a biopharmaceutical company. The Company has a pipeline of drug and diagnostic products in development for the treatment of conditions and diseases, such as enlarged prostate (benign prostatic hyperplasia (BPH)), Alzheimer’s disease (AD), E. coli O157:H7, contamination of food and drink products, and bacterial infections and for the diagnosis of AD and other indications. Its wholly owned subsidiaries include Nymox Corporation and Serex Inc., which conduct research and development, and some of the manufacturing for NicAlert and TobacAlert. Nymox also has rights for the use of statin drugs for the treatment and prevention of Alzheimer’s disease.